What is the best immunosuppressant combination in terms of antitumor effect in hepatocellular carcinoma?
Author:
Affiliation:
1. Department of Surgery; Seoul National University College of Medicine; Seoul South Korea
Funder
SNU R&DB Foundation
Publisher
Wiley
Subject
Infectious Diseases,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12588/fullpdf
Reference23 articles.
1. Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial;O'Grady;Lancet,2002
2. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence;Vivarelli;Ann Surg,2008
3. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression;Vivarelli;Liver Transpl,2005
4. Sirolimus: a potent new immunosuppressant for liver transplantation;Watson;Transplantation,1999
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical outcomes of gastric cancer surgery after liver transplantation;Annals of Surgical Treatment and Research;2023
2. Sirolimus Attenuates Calcineurin Inhibitor-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma;Transplantation Proceedings;2022-09
3. Reduced calcineurin inhibitor exposure with antibody induction and recurrent hepatocellular carcinoma after liver transplantation;Scandinavian Journal of Gastroenterology;2021-12-06
4. Sirolimus and MMF are insufficient immunosuppressants for regulation of the proliferation of CD133+EpCAM+ cell populations in HCC cell lines;Biomedical Reports;2020-10-20
5. Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial;Journal of Clinical Medicine;2020-10-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3